ST Elevation Myocardial Infarction in the elderly
Marcelo Franken1, Amit Nussbacher, Alberto Liberman
1INCOR Heart Institute, University of Sao Paulo Medical School, Av. Dr. Enéas Carvalho de Aguiar, 44-05403-000, São Paulo, Brasil.
Insights
Diagnosing and managing ST elevation myocardial infarction in elderly patients presents unique challenges due to atypical symptoms and underrepresentation in clinical trials, leading to higher mortality rates.
Area of Science:
- Cardiology
- Geriatric Medicine
- Internal Medicine
Background:
- Acute coronary syndromes (ACS) are a primary cause of mortality in the elderly population.
- Diagnosis of ACS in older adults is complicated by less frequent typical angina presentations.
- Elderly patients face greater morbidity and mortality from ACS compared to younger individuals.
Purpose of the Study:
- To outline the diagnostic and management challenges of ST elevation myocardial infarction (STEMI) specifically in elderly patients.
- To review the existing evidence pertaining to STEMI in the geriatric population.
- To highlight the underrepresentation of elderly individuals in pivotal clinical trials informing ACS guidelines.
Main Methods:
- Review of current literature and clinical guidelines.
- Analysis of challenges in diagnosing STEMI in the elderly.
- Discussion of management strategies for elderly STEMI patients.
- Examination of evidence-based recommendations and their applicability to older adults.
Main Results:
- Elderly patients with STEMI exhibit atypical symptoms, complicating early diagnosis.
- Older adults are disproportionately affected by higher morbidity and mortality rates post-STEMI.
- Significant underrepresentation of elderly patients in major clinical trials limits evidence-based treatment recommendations for this demographic.
Conclusions:
- There is a critical need for improved diagnostic and management strategies for STEMI in the elderly.
- Current evidence-based guidelines may not fully address the unique needs of older patients with STEMI.
- Further research and clinical trial inclusion are essential to optimize STEMI care for the aging population.
Abstract:
Acute coronary syndromes (ACS) are the leading causes of death in the elderly. The suspicion and diagnosis of ACS in this age group is more difficult, since typical angina is less frequent. The morbidity and mortality is greater in older age patients presenting ACS. Despite the higher prevalence and greater risk, elderly patients are underrepresented in major clinical trials from which evidence based recommendations are formulated. The authors describe, in this article, the challenges in the diagnosis and management of ST elevation myocardial infarction in the elderly, and discuss the available evidence.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...


